Key facts
- Tellgen (SHE: 300642) is a other based in Shanghai, China.
About Tellgen (SHE: 300642)
Tellgen Corp manufactures and distributes in vitro diagnostic devices for detection of tumor. Its products include tumor marker, human papillomavirus, real time PCR, DNA methylation, autoimmune antibody, infectious disease and others. The company has developed products in the fields of tumor detection, cervical cancer screening, DNA methylation detection, male infertility and prenatal and postnatal care. Its products include tumor marker series products, human papillomavirus series products, Y chromosome microdeletion detection products, real time PCR, autoimmune antibody, and others.
Free account
See the whole book
- ·Watchlist + alerts for Tellgen (SHE: 300642)'s activity
Create free account
No card required
Portfolio
Portfolio — not yet on record
No portfolio companies for Tellgen (SHE: 300642) are on record yet. Positions surface from round participations, filings, and coverage.
Pro members can request priority coverage with a 48-hour turnaround.